transporters and enzymes

0.0(0)
Studied by 0 people
call kaiCall Kai
learnLearn
examPractice Test
spaced repetitionSpaced Repetition
heart puzzleMatch
flashcardsFlashcards
GameKnowt Play
Card Sorting

1/6

encourage image

There's no tags or description

Looks like no tags are added yet.

7 Terms

1
New cards

State the normal extracellular and intracellular concentrations of Na+, K+, and Ca2+, and distinguish passive from active transport.

Resting ion gradients: Na+ is 145 mM [out] vs. 10 mM [in]; K+ is 4 mM [out] vs. 140 mM [in]; Ca2+ is 1 mM [out] vs. 0.1 µM [in]. Passive transport requires no ATP and moves solutes down their concentration gradient via simple diffusion (lipophilic/small uncharged molecules), ion channels, or passive transporters. Active transport requires ATP energy to move solutes against their concentration gradient.

2
New cards

Describe the structure, conformational mechanism, and three functional types of solute carrier transporters.

Transporters are multipass transmembrane proteins that bind specific solutes and undergo sequential conformational changes (binding -> transport -> release -> recovery) to move molecules across the membrane—making them much slower (~10^2–10^3 molecules/sec) than ion channels. Functional types: 1. Uniport (moves one solute A down its gradient, e.g., GLUT2). 2. Symport (co-transports solute A down its gradient to drive solute B against its gradient in the same direction). 3. Antiport (exchanges solute A and solute B in opposite directions, e.g., Na+/Ca2+ exchanger).

3
New cards

Explain the physiological role of the Na+/K+ ATPase and trace how digoxin increases cardiac contractility.

The Na+/K+ ATPase uses ATP (consuming ~1/3 of cellular energy) to pump 3 Na+ out and 2 K+ in, maintaining the electrochemical Na+ gradient that drives secondary active transporters like the Na+/Ca2+ exchanger (3 Na+ in, 1 Ca2+ out). Digoxin (from foxglove, Digitalis purpurea) inhibits the cardiac Na+/K+ ATPase -> intracellular Na+ rises -> the Na+ gradient shrinks -> Ca2+ extrusion via the Na+/Ca2+ exchanger decreases -> intracellular Ca2+ increases -> stronger cardiac contraction (used in heart failure/atrial fibrillation).

4
New cards

Explain the mechanism of action of antidepressant drugs targeting the serotonin transporter (SERT).

The serotonin transporter (SERT) uses the inward Na+ electrochemical gradient (maintained by Na+/K+ ATPase) to reuptake released serotonin from the synaptic cleft back into the presynaptic neuron. Antidepressant drugs block SERT, inhibiting reuptake and increasing extracellular synaptic serotonin levels.

5
New cards

Compare the properties and gating mechanisms of ion channels with those of transporters.

Ion channels form narrow, selective protein pores (specificity set by pore size and charge) that do not bind transported ions, allowing rapid passive flux (>10^7 ions/sec vs. 10^2–10^3/sec for transporters) strictly down electrochemical gradients. They switch between closed and open conformations via two main gating mechanisms: 1. Voltage-gated (opened by membrane depolarization, e.g., voltage-gated Na+ and Ca2+ channels). 2. Ligand-gated (opened by neurotransmitter/ligand binding, e.g., nicotinic acetylcholine receptor [nAChR]).

6
New cards

Trace the sequence of ion channel events at the neuromuscular junction and explain the action of tubocurarine.

  1. Action potential propagation opens axonal voltage-gated Na+ channels, depolarizing the nerve terminal. 2. Depolarization opens presynaptic voltage-gated Ca2+ channels; Ca2+ influx triggers acetylcholine (ACh) vesicle exocytosis. 3. ACh binds postsynaptic nicotinic ACh receptors (ligand-gated Na+ channels) on skeletal muscle, causing Na+ influx, muscle depolarization, and opening of muscle voltage-gated Na+ channels to trigger contraction. Tubocurarine (from South American curare arrow poison) blocks nicotinic ACh receptors, causing skeletal muscle relaxation during surgery.
7
New cards

Trace the six-step coupling of transporters and ion channels in pancreatic β-cell insulin secretion and state how sulfonylureas act.

  1. Blood glucose enters β-cells via the GLUT2 transporter. 2. Glucokinase and glycolysis/respiration metabolize glucose, raising the intracellular ATP/ADP ratio. 3. Elevated ATP closes ATP-sensitive K+ channels, preventing K+ efflux and causing membrane depolarization. 4. Depolarization opens voltage-gated Ca2+ channels. 5. Ca2+ influx triggers exocytosis of insulin storage granules (6. insulin release). Sulfonylureas (e.g., glibenclamide) directly block ATP-sensitive K+ channels to stimulate insulin secretion in type 2 diabetes.